ELIZABETH SIMPSON: Open Payments
NPI 1770732166 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,987 in 230 payments from 20 companies in 2025. Trend: 2023 $3,742 · 2024 $4,699 · 2025 $3,987
Food & beverage: $3,815Education: $172
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 51 | $858 |
| Janssen Biotech, Inc. | 44 | $768 |
| Novartis Pharmaceuticals Corporation | 21 | $360 |
| UCB, Inc. | 13 | $320 |
| Organon LLC | 14 | $247 |
| Incyte Corporation | 15 | $242 |
| Regeneron Healthcare Solutions, Inc. | 9 | $191 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 15 | $177 |
| PFIZER INC. | 11 | $161 |
| Lilly USA, LLC | 7 | $146 |
Products named: TREMFYA, SKYRIZI, RINVOQ, Bimzelx, DUPIXENT, OPZELURA, COSENTYX, VTAMA.
Industry payments across AL — which companies pay providers there.
